ES2148132T1 - Metodo de activacion de agentes fotosensitivos. - Google Patents

Metodo de activacion de agentes fotosensitivos.

Info

Publication number
ES2148132T1
ES2148132T1 ES99201064T ES99201064T ES2148132T1 ES 2148132 T1 ES2148132 T1 ES 2148132T1 ES 99201064 T ES99201064 T ES 99201064T ES 99201064 T ES99201064 T ES 99201064T ES 2148132 T1 ES2148132 T1 ES 2148132T1
Authority
ES
Spain
Prior art keywords
less
activation
habitual
animal
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES99201064T
Other languages
English (en)
Other versions
ES2148132T3 (es
Inventor
Anna M Richter
Julia G Levy
Elizabeth Waterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of ES2148132T1 publication Critical patent/ES2148132T1/es
Application granted granted Critical
Publication of ES2148132T3 publication Critical patent/ES2148132T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PRESENTA UN PROCEDIMIENTO PARA ADMINISTRAR TERAPIA FOTODINAMICA QUE COMIENZA CON LA ADMINISTRACION A UN ANIMAL DE UNA CANTIDAD EFECTIVA DE UN AGENTE FOTOSENSIBILIZANTE QUE ES MENOR DE ALREDEDOR DE LA MITAD DE LA DOSIS CLINICA HABITUAL DEL AGENTE FOTOSENSIBILIZANTE. ENTONCES, DESPUES DE UN INTERVALO POSTERIOR A LA INYECCION QUE ES MENOR DE ALREDEDOR DE UN CUARTO DEL INTERVALO HABITUAL, SE ADMINISTRA AL ANIMAL UNA DOSIS EFECTIVA DE LUZ QUE ES MENOR QUE ALREDEDOR DE LA MITAD DE LA DOSIS CLINICA HABITUAL DE LUZ UTILIZADA EN CONJUNCION CON EL AGENTE FOTOSENSIBILIZANTE.
ES99201064T 1992-11-20 1993-11-17 Metodo de activacion de agentes fotosensibles. Expired - Lifetime ES2148132T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97954692A 1992-11-20 1992-11-20
US979546 1992-11-20

Publications (2)

Publication Number Publication Date
ES2148132T1 true ES2148132T1 (es) 2000-10-16
ES2148132T3 ES2148132T3 (es) 2006-12-01

Family

ID=25526957

Family Applications (2)

Application Number Title Priority Date Filing Date
ES99201064T Expired - Lifetime ES2148132T3 (es) 1992-11-20 1993-11-17 Metodo de activacion de agentes fotosensibles.
ES94900024T Expired - Lifetime ES2143539T3 (es) 1992-11-20 1993-11-17 Uso de un agente fotosensibilizador.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES94900024T Expired - Lifetime ES2143539T3 (es) 1992-11-20 1993-11-17 Uso de un agente fotosensibilizador.

Country Status (20)

Country Link
US (2) US5705518A (es)
EP (2) EP0947222B1 (es)
JP (1) JP3146008B2 (es)
KR (1) KR100230588B1 (es)
AT (2) ATE189966T1 (es)
AU (1) AU679016B2 (es)
CA (1) CA2149636C (es)
DE (3) DE947222T1 (es)
DK (2) DK0680365T3 (es)
ES (2) ES2148132T3 (es)
FI (1) FI952436A7 (es)
GR (1) GR3033362T3 (es)
HU (1) HU224722B1 (es)
IL (1) IL107676A (es)
NO (1) NO323107B1 (es)
PH (1) PH31688A (es)
PL (1) PL172480B1 (es)
PT (2) PT947222E (es)
WO (1) WO1994012239A1 (es)
ZA (1) ZA938710B (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および／または治療剤
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
JP2961074B2 (ja) 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
JP2000500137A (ja) * 1995-11-06 2000-01-11 ニューヨーク・ブラッド・センター・インコーポレイテッド フタロシアニン及び赤色光を用いた赤血球細胞のウイルス不活性化処理
JP3845469B2 (ja) 1996-02-21 2006-11-15 明治製菓株式会社 眼底の新生血管の閉塞に用いる投与剤
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US6008889A (en) * 1997-04-16 1999-12-28 Zeng; Haishan Spectrometer system for diagnosis of skin disease
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
DE19721489A1 (de) * 1997-05-23 1998-11-26 Tibor Dr Nagypal System zur photodynamischen Behandlung von Lebewesen, deren Organen und/oder Geweben
US6128525A (en) * 1997-07-29 2000-10-03 Zeng; Haishan Apparatus and method to monitor photodynamic therapy (PDT)
US6096066A (en) * 1998-09-11 2000-08-01 Light Sciences Limited Partnership Conformal patch for administering light therapy to subcutaneous tumors
US6117862A (en) * 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534218A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
CA2358662A1 (en) * 1999-01-15 2000-07-20 James Chen Therapeutic compositions for metabolic bone disorders or bone metastases
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
AU7500200A (en) * 1999-09-24 2001-04-30 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
AU2001227837A1 (en) * 2000-01-12 2001-07-24 Light Sciences Corporation Novel treatment for eye disease
CA2403612A1 (en) * 2000-03-24 2001-10-11 Romulus Kimbro Brazzell Improved treatment of neovascularization
US6454790B1 (en) * 2000-07-21 2002-09-24 Ceramoptec Industries, Inc. Treatment for Barrett's syndrome
US7193706B2 (en) * 2000-08-02 2007-03-20 Arizona Board Of Regents, Acting On Behalf Of Arizona State University Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution
RU2195346C2 (ru) * 2001-03-15 2002-12-27 9 Лечебно-диагностический центр Министерства Обороны Российской Федерации Аппарат лазерного облучения крови
WO2003047592A1 (en) * 2001-12-03 2003-06-12 The Regents Of The University Of California Photodynamic therapy for the treatment of epilepsy
DE10162712A1 (de) * 2001-12-19 2003-07-17 Blutspendienst Der Landesverba Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten
EP1467760A2 (en) * 2002-01-23 2004-10-20 Light Sciences Corporation Systems and methods for photodynamic therapy
US7041121B1 (en) * 2002-01-31 2006-05-09 Medtronicvidamed, Inc. Apparatus for treating prostate cancer and method for same
DE60328496D1 (en) 2002-06-27 2009-09-03 Health Research Inc Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
EP2036908A3 (en) 2002-07-02 2009-05-13 Health Research, INC. Efficient synthesis of pyropheophorbide a derivates
EP1549268A2 (en) * 2002-10-03 2005-07-06 Light Sciences Corporation Excitation of photoreactive compounds in eye tissue
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
RU2248231C2 (ru) * 2003-03-05 2005-03-20 9 Лечебно-диагностический центр Министерства Обороны Российской Федерации Аппарат лазерного облучения крови
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US20060020033A1 (en) * 2004-07-21 2006-01-26 Ali Moiin Method for treating dermatological viral infections
US7465312B2 (en) * 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US20070299431A1 (en) * 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2011059216A2 (ko) * 2009-11-10 2011-05-19 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
KR101200210B1 (ko) * 2009-11-10 2012-11-09 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
GB2517707B (en) * 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521762A (en) 1981-08-27 1985-06-04 Gte Automatic Electric Laboratories, Incorporated Integratable D/A converter
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
EP0118411B1 (fr) 1983-03-07 1988-07-20 Jacinto Munoz Carcedo Perfectionnements aux systèmes d'ancrage pour panneaux de séparation
US4753958A (en) 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
DE68929063T2 (de) 1988-02-01 2000-02-24 Matsushita Electric Industrial Co., Ltd. Dreidimensionale bildformungsanordnung
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US4935498A (en) 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
CA2012175A1 (en) * 1989-03-31 1990-09-30 Michael W. Berns Photochemical treatment of blood vessels
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
CH684166A5 (it) * 1990-09-28 1994-07-29 Teclas Tecnologie Laser S A Apparecchiatura dedicata a radiazione rossa per fotochemioterapia.
WO1994006424A1 (en) * 1992-09-21 1994-03-31 Quadra Logic Technologies, Inc. Transcutaneous in vivo activation of photosensitive agents in blood

Also Published As

Publication number Publication date
EP0680365A1 (en) 1995-11-08
FI952436L (fi) 1995-07-05
CA2149636A1 (en) 1994-06-09
NO952004D0 (no) 1995-05-19
DK0680365T3 (da) 2000-06-05
ATE189966T1 (de) 2000-03-15
DE69327972D1 (de) 2000-04-06
DE69327972T2 (de) 2000-11-02
NO323107B1 (no) 2007-01-02
ES2148132T3 (es) 2006-12-01
ATE322932T1 (de) 2006-04-15
DE69334009T2 (de) 2006-11-23
IL107676A (en) 1999-11-30
DE947222T1 (de) 2000-05-04
PT947222E (pt) 2006-09-29
ES2143539T3 (es) 2000-05-16
JPH08505069A (ja) 1996-06-04
EP0947222B1 (en) 2006-04-12
PL309033A1 (en) 1995-09-18
PL172480B1 (pl) 1997-09-30
FI952436A0 (fi) 1995-05-19
AU679016B2 (en) 1997-06-19
WO1994012239A1 (en) 1994-06-09
GR3033362T3 (en) 2000-09-29
HU224722B1 (en) 2006-01-30
IL107676A0 (en) 1994-02-27
KR950704007A (ko) 1995-11-17
CA2149636C (en) 2001-04-03
JP3146008B2 (ja) 2001-03-12
NO952004L (no) 1995-07-11
EP0680365B1 (en) 2000-03-01
HU9501489D0 (en) 1995-07-28
PH31688A (en) 1999-01-18
ZA938710B (en) 1994-06-30
HK1025059A1 (en) 2000-11-03
EP0947222A2 (en) 1999-10-06
DE69334009D1 (de) 2006-05-24
AU5460094A (en) 1994-06-22
EP0947222A3 (en) 1999-10-27
HUT72037A (en) 1996-03-28
DK0947222T3 (da) 2006-09-04
FI952436A7 (fi) 1995-07-05
US5770619A (en) 1998-06-23
PT680365E (pt) 2000-07-31
KR100230588B1 (ko) 1999-12-01
US5705518A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
ES2148132T1 (es) Metodo de activacion de agentes fotosensitivos.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
ES2187659T3 (es) Tratamiento de la diabetes mellitus de tipo ii con agonistas de amilina.
ES2170136T3 (es) Formulaciones opioides para el tratamiento del dolor.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
PT90049A (pt) Forma de dosagem para administrar um medicamento para terapia humana
ES2164040T1 (es) Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos.
ES2060941T3 (es) Uso de nicotina para la fabricacion de un estuche para el tratamiento de condiciones susceptibles de dicho tratamiento.
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
AR020803A1 (es) Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento
ES2068705T3 (es) Tratamiento de la enfermedad neoplastica con interleuquina-10.
ES2058125T3 (es) Derivados de piperidina para el tratamiento del dolor.
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2181849T3 (es) Procedimiento para minimizar la perdida osea.
AR023185A1 (es) Tratamiento de cancer mejorado con temozolomida
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
ES2038064B1 (es) Instalacion portatil de vacunacion aviar.
AR007369A1 (es) El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados
AR003979A1 (es) Administracion transdermica de vorozol.
MX9206135A (es) Metodos
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
SE9101341D0 (sv) New medicinal use
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.